Cargando...
3PC-029 Calculation of annual economic impact of manufacturing avastin(®) syringes in the age-related macular degeneration treatment in our hospital
BACKGROUND: Following the obtaining of the Temporary Recommendation for Use (RTU) in 2015, Hospital Pharmacy Unit (HPU) manufactured syringes of Avastin(®) (bevacizumab) for treatment of age-related macular degeneration (AMD). Financial interest is significant, as cost of Avastin(®) is definitely lo...
Guardado en:
| Publicado en: | Eur J Hosp Pharm |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Group
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535831/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.81 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|